HR 7062
116th Congress
House
Health
Cardiovascular and respiratory health
Digestive and metabolic diseases
Drug therapy
Emergency medical services and trauma care
Health care coverage and access
Health technology, devices, supplies
Infectious and parasitic diseases
Medicare
Prescription drugs
Affordable Insulin for the COVID–19 Emergency Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 28, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 28, 2020
Introduced in House
Plain-English summary
Affordable Insulin for the COVID-19 Emergency Act
This bill eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.
What's happening now
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committees of jurisdiction
2